Contact TNF
About Us
Team
Pipeline
MYMD-1
®
Supera-CBD
Research
Clinical Trials
Investors
News
TNF News
Press Releases
Thought leadership
Perspectives
Subscribe
Contact TNF
Past Events
Investors
Investors
Overview
News & Events
Press Releases
IR Calendar
Email Alerts
Company Info
Management Team
Presentations
Contacts
FAQ
Financial Info
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Board of Directors
Board Committees
Governance Documents
Board Diversity Matrix
Sep 10, 2025 8:00 am EDT
H.C. Wainwright 27th Annual Global Investment Conference
May 20, 2025 10:00 am EDT
Annual Meeting of Stockholders
Mar 6, 2025 4:30 pm EDT
Investor Conference Call
Nov 25, 2024 10:00 am EDT
Annual Meeting of Stockholders
Jul 24, 2024 10:00 am EDT
Special Meeting of Shareholders
Oct 5 – Oct 6, 2023
BioFuture 2023 Meeting
Aug 2, 2023 4:30 pm EDT
MyMD Pharmaceutical Phase 2 Trial Update
Jul 31, 2023 10:00 am EDT
Annual Meeting of Stockholders
Mar 20, 2023 9:00 am CST
Society of Toxicology (SOT) 2023 Annual Meeting
Dec 14, 2022 10:00 am EDT
2022 Annual Meeting of Stockholders
Dec 6, 2022
British Society for Immunology (BSI) Congress 2022
Dec 8, 2021 4:00 pm EDT
Benzinga Global Small Cap Conference
Dec 2, 2021
Benchmark Company Discovery Conference
Oct 21, 2021 4:30 pm EDT
Dawson James Securities 6th Annual Small Cap Growth Conference
Oct 7, 2021 10:10 am EDT
Benzinga Rising Stars: Catalytic Small Cap Growth Conference
Sep 13, 2021 7:00 am EDT
H.C. Wainwright 23rd Annual Global Investment Conference
May 17, 2021 4:15 pm EDT
Business Update Conference Call
Apr 28, 2021 4:15 pm EDT
3rd Annual Neuroimmunology Drug Development Summit
View Upcoming Events
Email Alerts
Contacts
RSS News Feed
Subscribe to receive TNF announcements
Name
*
First
Last
Email
*
Phone
This field is for validation purposes and should be left unchanged.
